Current Approaches to the Pharmacologic Treatment of Core Symptoms Across the Lifespan of Autism Spectrum Disorder

被引:9
|
作者
Pandina, Gahan [1 ]
Ring, Robert H. [2 ,3 ]
Bangerter, Abigail [1 ]
Ness, Seth [1 ]
机构
[1] Janssen Res & Dev LLC, 1125 Trenton Harbouron Rd, Titusville, NJ 08560 USA
[2] Kaerus Biosci Ltd, London, England
[3] 2110 South Eagle Rd,Suite 392, Newtown, PA 18940 USA
关键词
ASD; Autism; Drug development; Therapeutics; Clinical trials; SOCIAL-BEHAVIOR; ENDOCANNABINOID SYSTEM; REPETITIVE BEHAVIORS; EARLY-CHILDHOOD; MOUSE MODEL; CHILDREN; OXYTOCIN; ADOLESCENTS; ADULTS; BRAIN;
D O I
10.1016/j.psc.2020.08.003
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
There are no approved medications for autism spectrum disorder (ASD) core symptoms. However, given the significant clinical need, children and adults with ASD are prescribed medication off label for core or associated conditions, sometimes based on limited evidence for effectiveness. Recent developments in the understanding of biologic basis of ASD have led to novel targets with potential to impact core symptoms, and several clinical trials are underway. Heterogeneity in course of development, cooccurring conditions, and age-related treatment response variability hampers study outcomes. Novel measures and approaches to ASD clinical trial design will help in development of effective pharmacologic treatments.
引用
收藏
页码:629 / +
页数:18
相关论文
共 50 条
  • [21] Characteristics of Brains in Autism Spectrum Disorder: Structure, Function and Connectivity across the Lifespan
    Ha, Sungji
    Sohn, In-Jung
    Kim, Namwook
    Sim, Hyeon Jeong
    Cheon, Keun-Ah
    [J]. EXPERIMENTAL NEUROBIOLOGY, 2015, 24 (04) : 273 - 284
  • [22] Priority service needs and receipt across the lifespan for individuals with autism spectrum disorder
    Lai, Jonathan K. Y.
    Weiss, Jonathan A.
    [J]. AUTISM RESEARCH, 2017, 10 (08) : 1436 - 1447
  • [23] Reactive and Proactive Interference Control in Adults With Autism Spectrum Disorder Across the Lifespan
    Lever, Anne G.
    Ridderinkhof, K. Richard
    Marsman, Maarten
    Geurts, Hilde M.
    [J]. DEVELOPMENTAL PSYCHOLOGY, 2017, 53 (02) : 379 - 395
  • [24] Challenges in the diagnosis and treatment of depression in autism spectrum disorders across the lifespan
    Chandrasekhar, Tara
    Sikich, Linmarie
    [J]. DIALOGUES IN CLINICAL NEUROSCIENCE, 2015, 17 (02) : 219 - 227
  • [25] PSYCHOPHARMACOLOGICAL TREATMENT OF ANXIETY SYMPTOMS IN AUTISM SPECTRUM DISORDER
    Hardan, Antonio
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (10): : S325 - S326
  • [26] Focus on Autism Spectrum Disorder: Issues and Treatment Approaches
    Betz, Cecily L.
    [J]. JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES, 2016, 31 (06): : 565 - 566
  • [27] Novel Mechanisms and Treatment Approaches in Autism Spectrum Disorder
    Brian, Jessica
    Doyle-Thomas, Krissy
    Baribeau, Danielle
    Anagnostou, Evdokia
    [J]. DISCOVERY MEDICINE, 2016, 22 (119) : 48 - 55
  • [28] Current nutritional approaches in managing autism spectrum disorder: A review
    Cekici, Hande
    Sanlier, Nevin
    [J]. NUTRITIONAL NEUROSCIENCE, 2019, 22 (03) : 145 - 155
  • [29] Cannabinoids as alleviating treatment for core symptoms of autism spectrum disorder in children and adolescents: a systematic review
    Ibsen, Emma Wen Dieperink
    Thomsen, Per Hove
    [J]. NORDIC JOURNAL OF PSYCHIATRY, 2024,
  • [30] Age-related Differences in Cognition across the Adult Lifespan in Autism Spectrum Disorder
    Lever, Anne G.
    Geurts, Hilde M.
    [J]. AUTISM RESEARCH, 2016, 9 (06) : 666 - 676